Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease-Reference-Cited by-同舟云学术

Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease

Published:2018-08 Issue:8 Volume:11 Page:1045-1055
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Ferreira de Souza Thiago,Quinaglia A.C. Silva Thiago,Osorio Costa Felipe,Shah Ravi,Neilan Tomas G.,Velloso Lício,Nadruz Wilson,Brenelli Fabricio,Sposito Andrei Carvalho,Matos-Souza Jose Roberto,Cendes Fernando,Coelho Otávio Rizzi,Jerosch-Herold Michael,Coelho-Filho Otavio Rizzi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference37 articles.

1. Doxorubicin-induced cardiomyopathy;Singal;N Engl J Med,1998

2. Doxorubicin-induced cardiomyopathy;Swain;N Engl J Med,1999

3. Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging;Aiken;Clin Nucl Med,2009

4. A mouse model for juvenile doxorubicin-induced cardiac dysfunction;Zhu;Pediatr Res,2008

5. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway;Zhu;Circulation,2009

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study;The Breast;2024-08

2. Cardiac MRI for clinical dilated cardiomyopathy: Improved diagnostic power via combined T1, T2, and ECV;Radiography;2024-05

3. The Significance of Parametric Mapping in Advanced Cardiac Imaging;Cardiology in Review;2024-04-08

4. Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma;Cardio-Oncology;2024-04-04

5. Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control;JACC: CardioOncology;2024-04